The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Airway and Systemic Inflammation and Decline in Lung Function in Patients With COPD
Open accessAbstract
Study objectives Patients with COPD experience lower airway and systemic inflammation, and an accelerated decline in FEV1. There is no evidence on whether this inflammation changes over time, or if it is associated with a faster decline in FEV1. Patients and design A cohort of 148 COPD patients (100 men) was monitored daily for a median of 2.91 years (interquartile range [IQR], 2.1 to 4.8). At recruitment, median age was 68.5 years (IQR, 62.5 to 73.6) and FEV1 as percentage of predicted (FEV1%Pred) was 38.5% (IQR, 27.7 to 50.3). Results During the study, the patients experienced 1,389 exacerbations, a median of 2.52/yr (IQR, 1.48 to 3.96) and FEV1 declined by 40.2 mL/yr or as FEV1%Pred by 1.5%/yr. Concerning inflammatory markers, sputum interleukin (IL)-6 rose by 9 pg/mL/yr, sputum neutrophil count rose by 1.64 × 106 cells per gram sputum per year, an plasma fibrinogen rose by 0.10 g/L/yr (all p < 0.05). Patients with frequent exacerbations (≥ 2.52/yr) had a faster rise over time in plasma fibrinogen and sputum IL-6 of 0.063 g/L/yr (p = 0.046, n = 130) and 29.5 pg/mL/yr (p < 0.001, n = 98), respectively, compared to patients with infrequent exacerbations (< 2.52/yr). Using the earliest stable (nonexacerbation) measured marker, patients whose IL-6 exceeded the group median had a faster FEV1%Pred decline of 0.42%/yr (p = 0.018). Similarly, a high neutrophil count or fibrinogen were associated with a faster FEV1%Pred decline of 0.97%/yr (p = 0.001) and 0.40%/yr (p = 0.014), respectively. Conclusions In COPD, airway and systemic inflammatory markers increase over time; high levels of these markers are associated with a faster decline in lung function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
Clauss, A. (1957) · Acta Haematologica · doi:10.1159/000205234 · Cited by 3,208
Donaldson, G. C. (2002) · Thorax · doi:10.1136/thorax.57.10.847 · Cited by 2,272
Self-citationEvidence-based health policy—lessons from the Global Burden of Disease Study
Murray, C. J. L., & Lopez, A. D. (1996) · Science · doi:10.1126/science.274.5288.740 · Cited by 2,178
Danesh, J., Collins, R., Appleby, P., & Peto, R. (1998) · JAMA · doi:10.1001/jama.279.18.1477 · Cited by 2,026
Anthonisen, N. R. (1994) · JAMA · doi:10.1001/jama.1994.03520190043033 · Cited by 1,341
Time Course and Recovery of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease
SEEMUNGAL, T. A. R., DONALDSON, G. C., BHOWMIK, A., JEFFRIES, D. J., & WEDZICHA, J. A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.5.9908022 · Cited by 1,179
Self-citationSin, D. D., & Man, S. F. P. (2003) · Circulation · doi:10.1161/01.cir.0000056767.69054.b3 · Cited by 1,082
SEEMUNGAL, T., HARPER-OWEN, R., BHOWMIK, A., MORIC, I., SANDERSON, G., MESSAGE, S., MacCALLUM, P., MEADE, T. W., JEFFRIES, D. J., JOHNSTON, S. L., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.9.2105011 · Cited by 1,018
Self-citationHole, D. J., Watt, G. C. M., Davey-Smith, G., Hart, C. L., Gillis, C. R., & Hawthorne, V. M. (1996) · BMJ · doi:10.1136/bmj.313.7059.711 · Cited by 911
Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations
Bhowmik, A. (2000) · Thorax · doi:10.1136/thorax.55.2.114 · Cited by 730
Self-citationMEADE, T. (1993) · The Lancet · doi:10.1016/0140-6736(93)92062-x · Cited by 711
Patel, I. S. (2002) · Thorax · doi:10.1136/thorax.57.9.759 · Cited by 690
Self-citationKANNER, R. E., ANTHONISEN, N. R., & CONNETT, J. E. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.3.2010017 · Cited by 583
Severity of Airflow Limitation Is Associated with Severity of Airway Inflammation in Smokers
DI STEFANO, A., CAPELLI, A., LUSUARDI, M., BALBO, P., VECCHIO, C., MAESTRELLI, P., MAPP, C. E., FABBRI, L. M., DONNER, C. F., & SAETTA, M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.4.9802078 · Cited by 572
Quality of life changes in COPD patients treated with salmeterol.
Jones, P. W., & Bosh, T. K. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.4.9105068 · Cited by 494
Spruit, M. A. (2003) · Thorax · doi:10.1136/thorax.58.9.752 · Cited by 476
Stanescu, D., Sanna, A., Veriter, C., Kostianev, S., Calcagni, P. G., Fabbri, L. M., & Maestrelli, P. (1996) · Thorax · doi:10.1136/thx.51.3.267 · Cited by 462
Seemungal, T., MacCallum, P., Paul, E., Donaldson, G., Bhowmik, A., Jeffries, D., Meade, T., & Wedzicha, J. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613998 · Cited by 447
Self-citationHill, A. T., Campbell, E. J., Hill, S. L., Bayley, D. L., & Stockley, R. A. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00507-6 · Cited by 414
Vernooy, J. H., Küçükaycan, M., Jacobs, J. A., Chavannes, N. H., Buurman, W. A., Dentener, M. A., & Wouters, E. F. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2202023 · Cited by 379
Inflammatory Response and Body Composition in Chronic Obstructive Pulmonary Disease
EID, A. A., IONESCU, A. A., NIXON, L. S., LEWIS-JENKINS, V., MATTHEWS, S. B., GRIFFITHS, T. L., & SHALE, D. J. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.8.2008109 · Cited by 376
Soler, N., Ewig, S., Torres, A., Filella, X., Gonzalez, J., & Zaubet, A. (1999) · European Respiratory Journal · doi:10.1183/09031936.99.14510159 · Cited by 371
Airway Bacterial Load and FEV 1 Decline in Patients with Chronic Obstructive Pulmonary Disease
Wilkinson, T. M. A., Patel, I. S., Wilks, M., Donaldson, G. C., & Wedzicha, J. A. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1179oc · Cited by 370
Self-citationDAHL, M., TYBJŒRG-HANSEN, A., VESTBO, J., LANGE, P., & NORDESTGAARD, B. G. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.6.2010067 · Cited by 260
Turato, G., Zuin, R., Miniati, M., Baraldo, S., Rea, F., Beghé, B., Monti, S., Formichi, B., Boschetto, P., Harari, S., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2111084 · Cited by 254
Jones, P. W., Willits, L. R., Burge, P. S., & Calverley, P. M. A. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00013303 · Cited by 249
Sutherland, E. R. (2003) · Thorax · doi:10.1136/thorax.58.11.937 · Cited by 220
Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease
Zalacain, R., Sobradillo, V., Amilibia, J., Barron, J., Achotegui, V., Pijoan, J. I., & Llorente, J. L. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.13b21.x · Cited by 210
Chronic obstructive pulmonary disease * 5: Systemic effects of COPD
Wouters, E. F. M. (2002) · Thorax · doi:10.1136/thorax.57.12.1067 · Cited by 204
Dentener, M. A. (2001) · Thorax · doi:10.1136/thorax.56.9.721 · Cited by 165
Signs and symptoms in common colds
Tyrrell, D. A. J., Cohen, S., & Schilarb, J. E. (1993) · Epidemiology and Infection · doi:10.1017/s0950268800056764 · Cited by 142
Spirometric findings and mortality in never-smokers
Lange, P. (1990) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(90)90070-6 · Cited by 128
The effect of age on protein metabolism
Short, K. R., & Nair, K. S. (2000) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200001000-00007 · Cited by 121
Which spirometric indices best predict subsequent death from chronic obstructive pulmonary disease?
Thomason, M. J. (2000) · Thorax · doi:10.1136/thorax.55.9.785 · Cited by 55
(2000) · doi:10.1002/1099-0496(200010)30:4<330::aid-ppul10>3.0.co;2-d
Cited by
Systemic manifestations and comorbidities of COPD
Barnes, P. J., & Celli, B. R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00128008 · Cited by 1,820
COPD exacerbations: Defining their cause and prevention
Wedzicha, J. A., & Seemungal, T. A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61382-8 · Cited by 1,370
Self-citationOutcomes for COPD pharmacological trials: from lung function to biomarkers
Cazzola, M., MacNee, W., Martinez, F. J., Rabe, K. F., Franciosi, L. G., Barnes, P. J., Brusasco, V., Burge, P. S., Calverley, P. M. A., Celli, B. R., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00099306 · Cited by 858
Self-citationRole of IL-6 in Asthma and Other Inflammatory Pulmonary Diseases
Rincon, M., & Irvin, C. G. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4874 · Cited by 621
Increased Risk of Myocardial Infarction and Stroke Following Exacerbation of COPD
Donaldson, G. C., Hurst, J. R., Smith, C. J., Hubbard, R. B., & Wedzicha, J. A. (2010) · Chest · doi:10.1378/chest.09-2029 · Cited by 514
Self-citation
Metadata
- Authors
- Donaldson, G. C., Seemungal, T. A. R., Patel, I. S., Bhowmik, A., Wilkinson, T. M. A., Hurst, J. R., MacCallum, P. K., & Wedzicha, J. A.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2005-10
- Volume
- 128
- Issue
- 4
- Pages
- 1995-2004
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W1571712967
- Cited by
- 480
- References
- 35
- FWCI
- 16.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.